A few months before Livongo and Teladoc Health inked a deal that valued Livongo at $18.5B, Jennifer Schneider, MD, MS, President of Livongo, took the stage at the StartUp Health Festival. Her telling of the company’s mission – to empower people with chronic conditions to live better and healthier lives – provides important context for the historic merger.
Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.